Thalidomide-benzo
98%
- Product Code: 121694
CAS:
458151-34-3
Molecular Weight: | 308.29 g./mol | Molecular Formula: | C₁₇H₁₂N₂O₄ |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | 2-8°C |
Product Description:
Thalidomide-benzo is primarily utilized in the field of medicinal chemistry and pharmaceutical research due to its potential therapeutic properties. It is often studied for its anti-inflammatory, immunomodulatory, and anti-angiogenic effects, which make it a candidate for treating conditions such as certain cancers, autoimmune diseases, and inflammatory disorders. Researchers explore its ability to inhibit the production of tumor necrosis factor-alpha (TNF-α), a key cytokine involved in inflammation. Additionally, its structural modifications, like the benzo group, are investigated to enhance its efficacy, reduce side effects, and improve pharmacokinetic properties. This compound is also of interest in the development of targeted therapies, particularly in diseases where angiogenesis plays a critical role, such as multiple myeloma and other solid tumors.
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.001 | 10-20 days | ฿23,040.00 |
+
-
|
0.005 | 10-20 days | ฿66,240.00 |
+
-
|
Thalidomide-benzo
Thalidomide-benzo is primarily utilized in the field of medicinal chemistry and pharmaceutical research due to its potential therapeutic properties. It is often studied for its anti-inflammatory, immunomodulatory, and anti-angiogenic effects, which make it a candidate for treating conditions such as certain cancers, autoimmune diseases, and inflammatory disorders. Researchers explore its ability to inhibit the production of tumor necrosis factor-alpha (TNF-α), a key cytokine involved in inflammation. Additionally, its structural modifications, like the benzo group, are investigated to enhance its efficacy, reduce side effects, and improve pharmacokinetic properties. This compound is also of interest in the development of targeted therapies, particularly in diseases where angiogenesis plays a critical role, such as multiple myeloma and other solid tumors.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :